Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

GT198 Is a Target of Oncology Drugs and Anticancer Herbs

Frontiers in Oral Health(2021)10.3389/froh.2021.679460Source: DataRank Database

GT198 Is a Target of Oncology Drugs and Anticancer Herbs is a research paper published in Frontiers in Oral Health (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.22)OA: goldTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Jie Gao ORCID,Liyong Zhang ORCID,Nahid F. Mivechi ORCID,Lan Ko ORCID,Junfeng Pang ORCID

Live enrichment

PubMed:34476412 PMC:PMC8409151 OpenAlex:https://openalex.org/W3169823497

NCI NIH HHS

Grant: R01 CA132640

NCI NIH HHS

Grant: R01 CA062130

National Institutes of Health

Grant: 5R01CA132640-14

Role of heat shock factors (Hsfs) in tumorigenesis

FWCI

0.22

Citation Percentile

0.5%

Citation Trend

2021

2022

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/froh.2021.679460/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/froh.2021.679460/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/froh.2021.679460/full

journalhttps://doi.org/10.3389/froh.2021.679460

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34476412

Fields of Study

PI3K/AKT/mTOR signaling in cancerCancer, Lipids, and MetabolismCancer Genomics and Diagnostics0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

EtoposidePaclitaxelPharmacologyDoxorubicinCancer researchCancerMitoxantroneTopoisomeraseBiologyIn vitroMedicineChemotherapyInternal medicineBiochemistryTumor angiogenesisOral CancerGt198Anticancer HerbsOncology Drug TargetDentistryRK1-715Oral Health

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being